Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy.
Miltenyi Biotec offers research and clinical grade products for sample preparation, cell separation, flow cytometry, and cell culture applications. The company has more than 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer.
MTIF has partnered with Anthony Nolan and Miltenyi Biotec to help accelerate Cell and Gene therapies on the path to market.
The Cell and Gene Therapy community in the UK offers huge potential for the development of advanced therapy medicinal products. However, barriers in early phase development are high since it requires scientific expertise, research funding and millions of pounds in laboratory space, manufacturing equipment, and access to biological raw materials.
To solve this issue, we have combined our scientific knowledge and capabilities to facilitate more efficient development, providing an environment which SMEs can use to translate their research through to early-stage clinical development.